보험금
1. The Plaintiff:
A. On February 2016, 2016, the Defendant M&A Co., Ltd.: KRW 30,400,000 and KRW 10,400 among them.
(a) in the case of a disease (see Table 2) classified as malicious life;
The diagnosis and confirmation of cancer shall be made by a person who holds a professional doctor's license of autopsy pathology or clinical pathology, and this diagnosis shall be based on the present opinion on the organization or blood test.
However, if it is not possible to conduct the above pathological diagnosis, the clinical diagnosis of cancer is admitted as evidence of cancer.
In such cases, I shall have a documented record or evidence proving that the insured has been under diagnosis or treatment as cancer.
[Attachment II] The following diseases are the Korean Standard Disease Death Classification (Statistics Notice No. 1993-3, January 1, 1995) of the 3th revised Korean Standard Disease Disease Classification Clause. < Amended by Presidential Decree No. 14870, Jan. 1, 1995>
In the Korean Standard Disease Classification after the revision of the Classification Items C20* 4, the disease shall also be included in the categories of occupational categories, if there is a disease prescribed in the terms and conditions in addition to the above disease.
B. Insurance contract between the Plaintiff and the Defendant Han Korean Life Insurance Co., Ltd.) on August 7, 1995 between the Plaintiff and the Plaintiff Han Korean Life Insurance Co., Ltd. (hereinafter “Defendant Han Korean Life Insurance”).
(i) When concluding an insurance contract with the name of Class 2 of healthy life, a special agreement containing a clause that, at the first time, the insurance amount (11. million won) of the purchase of cancer (11.0 million won) with the cancer treatment fund (11.0 million won) and 30% (3.3 million won) of the purchase amount (11.0 million won) of the purchase of the insurance amount (3.3 million won) with the cancer surgery fund for the first time when the diagnosis and determination is finalized with the cancer and the diagnosis is performed for a direct purpose of the cancer (hereinafter “instant Type 3 insurance contract”).
2) Of the terms and conditions of the instant insurance contract, the part relating to the instant case is as follows.
Article 3. The definition and diagnosis of cancer; and